Enerkon Solar
International Inc. (ENKS) Announce
Filing of Federal Action in Reno, NV
to invalidate 14.2
million shares in several previous transactions of former
management and 2 service providers who did not
perform
New York, NY -- June 15, 2021 -- InvestorsHub
NewsWire -- Today, Enerkon Solar International Inc. (OTC
PINK: ENKS) an international holding company – consisting of 6
companies incorporated in the USA and UK - investing in major top
market segments (Renewable Energy, Solar – Hydrogen Production, New
Disruptive Technologies, Patents and Trademarks, Biotech, Defense
and other vibrant market segments) issued the following statement
through the Companies CEO MR. Benjamin Ballout who
stated:
"Enerkon Solar International Inc. (OTC
PINK: ENKS) Announce Filing of Federal Action in Reno NV to
invalidate 14.2 million shares in several previous transactions of
former management and 2 service providers who did not
perform."
ENKS Chairman Mr. Ballout further states that this
aggressive action is a testament to our resolve in maintaining the
heist level of good governance – compliance, and a zero-tolerance
policy for any misbehavior from any commercial entities or
individuals who may seek to misbehave in relation to ENKS or its
equity.
"While we have leave to amend the complaint to add
others the defendants are comprised of former management or from
before we took over the public company as we were a private firm
initially, and others such as 2 service providers who failed to
provide any services in exchange for payment in 2018-2019 0 this
payment was in the form of restricted common stock and these shares
are the ones we seek to have the federal Judge Invalidate and
retire back to treasury of the company for the benefit of all
current shareholders.
"We are pleased to expend the cost of litigation
to prosecute these allegations - as the benefit of potential
invalidation of these 14.2+ shares far outweigh the financial cost,
many times over"
"ENKS is always at the forefront – protecting
shareholder value."
"ENKS will report on the progress of our action,
as we have any developments to report and we are proud to be
associated with the prestigious law firm of Cohen & Johnston
PC."
"Updates on Audit status and other corporate
actions associated with the second phase of our share conversion to
preferred already underway will be reported as the process
completes with results posted on the reviews company profile on OTC
Markets website (which will take 5-7 days to appear
adjusted)."
"Lastly, ENKS will post Video of the ALBAYRAKLAR
Defense Unit Weapon System (New Taser and other items) related to
our Joint Production agreement signed last year for public review
as we will restart our activities in this regard on invitation of
Adnan Al BAYRAK CEO."
The foregoing statements are forward-looking
statements, and as such, they may or may not reflect the results
which could transpire in the future which should be negative or not
transpire at all due to circumstances or other reasons and
investors, shareholders, or others should not rely on these
forward-looking statements to ascertain any value if any of
ENKS or to make any investment decisions and to take note that
this is not an offer to buy or sell securities or an endorsement
of ENKS for investment purposes as all investment carry a risk
of loss sometimes a total loss of your investment in Micro cap
shares markets or any market and therefore such statements or plans
should not be relied upon for any business decisions of any kind -
Approval and permissions required by federal regulations may or may
not be approved and if not approved may result in the loss of all
value and all investments in products requiring such regulatory
permissions to market and sell. These statements are made as
forward-looking statements for educational purposes only in
accordance with the rules and regulations which pertain to the
same.
Enerkon Solar International Inc.
www.enerkoninternational.com
info@enerkoninternational.com
New HQ Address in New York at:
Enerkon Solar International Inc.
477 Madison Avenue
New York, NY 10022 USA
Tel. +1 (877) 573-7797
Tel. +1 (718) 709-7889